Efruxifermin, CAS 2375240-92-7

Product Description: Efruxifermin is an Fc-FGF21 fusion protein (human IgG1 Fc domain linked to a modified human FGF21). Efruxifermin has prolonged half-life and enhanced receptor affinity compared with native human FGF21. Efruxifermin can be used for the research of non-alcoholic steatohepatitis[1].

Applications: Metabolism-protein/nucleotide metabolism

Formula: N/A

References: [1]Tillman EJ, et al. Efruxifermin, a long-acting Fc-fusion FGF21 analogue, reduces body weight gain but does not increase sympathetic tone or urine volume in Sprague Dawley rats. Br J Pharmacol. 2022 Apr;179(7):1384-1394.

CAS Number: 2375240-92-7

Molecular Weight: N/A

Compound Purity: 98.32

Research Area: Metabolic Disease

Solubility: 10 mM in DMSO

Target: FGFR

• Artikelnummer: MEXHY-P99930-10
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99930-10
• Verpackungseinheit: 10 mg
• Mengeneinheit: STK
• Konjugat: Unconjugated